Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
作者： Renate De Smedt , Julie Morscio , Steven Goossens , Pieter Van Vlierberghe
DOI: 10.1016/J.BLRE.2019.100591
关键词:
摘要: … as well as steroid resistance has also been observed for JAK1 mutant T-ALLs [41]. Importantly, this study also showed that sensitivity to vincristine and L-asparaginase was unaffected in …
sci-hub.se 参考文章(154)
Bronisława Szarzyńska‐Zawadzka, Joachim B. Kunz, Łukasz Sędek, Maria Kosmalska, Katarzyna Zdon, Przemysław Biecek, Obul R. Bandapalli, Monika Kraszewska‐Hamilton, Roman Jaksik, Monika Drobna, Jerzy R. Kowalczyk, Tomasz Szczepański, Pieter Van Vlierberghe, Andreas E. Kulozik, Michał Witt, Małgorzata Dawidowska, PTEN abnormalities predict poor outcome in children with T‐cell acute lymphoblastic leukemia treated according to ALL IC‐BFM protocols American Journal of Hematology. ,vol. 94, ,(2019) , 10.1002/AJH.25396
Yandong Shen, Kyle Crassini, Suneet Sandhu, Narjis Fatima, Richard I. Christopherson, Stephen P. Mulligan, O. Giles Best, Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment Leukemia & Lymphoma. ,vol. 60, pp. 1632- 1643 ,(2019) , 10.1080/10428194.2018.1542148
Livia Weijenborg Campos, Priscila Pini Zenatti, Leonardo Granato Pissinato, Gisele O. Libanio Rodrigues, Leonardo Luís Artico, Thais Rafael Guimarães, Leticia Fröhlich Archangelo, Leandro Martínez, Andrew J. Brooks, José Andrés Yunes, Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. Blood. ,vol. 133, pp. 1259- 1263 ,(2019) , 10.1182/BLOOD-2018-09-872945
Padma Akkapeddi, Rita Fragoso, Julie A. Hixon, Ana Sofia Ramalho, Mariana L. Oliveira, Tânia Carvalho, Andreas Gloger, Mattia Matasci, Francisco Corzana, Scott K. Durum, Dario Neri, Gonçalo J. L. Bernardes, João T. Barata, A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia. Leukemia. ,vol. 33, pp. 2155- 2168 ,(2019) , 10.1038/S41375-019-0434-8
Ju, Guo, Yan, Zhi, Ling, Qiang, Li, Yi, Zhu, Ping, Chen, Gao, Xia, Gu, Ma, Zhou, Rapamycin Sensitizes Glucocorticoid Resistant Acute Lymphoblastic Leukemia CEM-C1 Cells to Dexamethasone Induced Apoptosis through both mTOR Suppression and Up-Regulation and Activation of Glucocorticoid Receptor 生物医学与环境科学：英文版. ,vol. 26, pp. 371- 381 ,(2013)
Carmen Blanco-Aparicio, Ana María García Collazo, Julen Oyarzabal, Juan F. Leal, María Isabel Albarán, Francisco Ramos Lima, Belén Pequeño, Nuria Ajenjo, Mercedes Becerra, Patricia Alfonso, María Isabel Reymundo, Irene Palacios, Genoveva Mateos, Helena Quiñones, Ana Corrionero, Amancio Carnero, Paolo Pevarello, Ana Rodríguez Lopez, Jesús Fominaya, Joaquín Pastor, James R. Bischoff, Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition Cancer Letters. ,vol. 300, pp. 145- 153 ,(2011) , 10.1016/J.CANLET.2010.09.016
A Carracedo, P P Pandolfi, The PTEN–PI3K pathway: of feedbacks and cross-talks Oncogene. ,vol. 27, pp. 5527- 5541 ,(2008) , 10.1038/ONC.2008.247
Peter C. Hollenhorst, RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites. Small GTPases. ,vol. 3, pp. 154- 158 ,(2012) , 10.4161/SGTP.19630
Sarah K. Tasian, Michelle Y. Doral, Michael J. Borowitz, Brent L. Wood, I-Ming Chen, Richard C. Harvey, Julie M. Gastier-Foster, Cheryl L. Willman, Stephen P. Hunger, Charles G. Mullighan, Mignon L. Loh, Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2 -rearranged B-precursor acute lymphoblastic leukemia Blood. ,vol. 120, pp. 833- 842 ,(2012) , 10.1182/BLOOD-2011-12-389932
Shawn A. Mahmud, Luke S. Manlove, Michael A. Farrar, Interleukin-2 and STAT5 in regulatory T cell development and function. JAK-STAT. ,vol. 2, ,(2013) , 10.4161/JKST.23154